Interestingly, we detected decreased AHR activation in MS brain lesions as indicated by the expression of the AHR target gene CYP1B1, concomitant with decreased levels of AHR agonists in MS sera detected using a cell-based reporter assay and mass spectrometry8. Here, CYP1B1 is linked to myeloid sarcoma.